|
|
|
|
pmid:
|
Nakamura T et al. |
Absorption and metabolism of 4-hydroxyderricin and xanthoangelol after oral administration of Angelica keiskei (Ashitaba) extract in mice. |
2012 |
Arch. Biochem. Biophys. |
pmid:22452965
|
Ohkura N et al. |
Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production. |
2011 Nov-Dec |
Biofactors |
pmid:22038782
|
Motani K et al. |
Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma. |
2008 |
Biol. Pharm. Bull. |
pmid:18379052
|
Sugii M et al. |
Xanthoangelol D isolated from the roots of Angelica keiskei inhibits endothelin-1 production through the suppression of nuclear factor-kappaB. |
2005 |
Biol. Pharm. Bull. |
pmid:15802795
|
Tabata K et al. |
Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. |
2005 |
Biol. Pharm. Bull. |
pmid:16079483
|
Ohnogi H et al. |
Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes. |
2012 |
Biosci. Biotechnol. Biochem. |
pmid:22738967
|
Akihisa T et al. |
Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. |
2003 |
Cancer Lett. |
pmid:14607326
|
Teng Y et al. |
3'-Geranyl-mono-substituted chalcone Xanthoangelovl induces apoptosis in human leukemia K562Â cells via activation of mitochondrial pathway. |
2017 |
Chem. Biol. Interact. |
pmid:27908776
|
Ogawa H et al. |
Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17250645
|